Dongbang Medical Co., Ltd (KOSDAQ:240550)

Market Cap	144.65B -29.0%
Revenue (ttm)	111.86B +9.2%
Net Income	9.62B +213.5%
EPS	502.75 +162.4%
Shares Out	20.93M
PE Ratio	13.74
Forward PE	6.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,490
Average Volume	157,764
Open	6,740.00
Previous Close	6,850.00
Day's Range	6,670.00 - 6,940.00
52-Week Range	6,340.00 - 15,130.00
Beta	n/a
RSI	40.02
Earnings Date	Mar 20, 2026

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1985
• Employees: 282
• Stock Exchange: KOSDAQ
• Ticker Symbol: 240550

Financial Performance

In 2024, Dongbang Medical's revenue was 105.11 billion, an increase of 15.67% compared to the previous year's 90.88 billion. Earnings were 2.91 billion, a decrease of -70.19%.